Ultima-DES (1-3) 1mg-USA

Ultima-DES (1-3), 1 mg

Ultima-DES (1-3) 1 mg contains DES(1-3) IGF-1, a truncated form of insulin-like growth factor-1 (IGF-1). It has attracted significant interest in fitness and muscle-growth research because of its relationship with IGF-1 receptor signaling, muscle protein synthesis, cellular growth, and anabolic pathways.

DES(1-3) IGF-1 lacks the first three amino acids of native IGF-1. This structural difference substantially reduces its interaction with IGF-binding proteins, allowing greater availability of the peptide for IGF-1 receptor activity. Research has found DES(1-3) IGF-1 to be considerably more potent than native IGF-1 in certain cell and experimental models.

How it works

DES(1-3) IGF-1 binds to the IGF-1 receptor (IGF-1R) and activates signaling pathways associated with cellular growth and protein synthesis.

Its reduced binding to IGF-binding proteins is one of its defining characteristics. This allows more of the peptide to remain available for receptor interaction, contributing to its strong activity in experimental models. Research has examined downstream pathways including PI3K/Akt and MAPK/ERK, which are involved in muscle growth, cellular proliferation, and tissue development.

Proper Use and Dosage

The listed product contains 1 mg (1,000 mcg) per vial.

For the 1 mg presentation:

• 10 mcg = 100 administrations
• 20 mcg = 50 administrations
• 25 mcg = 40 administrations
• 50 mcg = 20 administrations
• 100 mcg = 10 administrations
• 200 mcg = 5 administrations
• 500 mcg = 2 administrations
• 1,000 mcg = 1 full vial

Benefits

Ultima-DES (1-3) is particularly interesting for research involving muscle growth, anabolic signaling, cellular development, and tissue adaptation.

Key areas of interest include:

• Supports IGF-1 receptor research
• Investigated for muscle protein synthesis
• Supports anabolic signaling pathways
• Studied for muscle-cell growth and hypertrophy
• Investigated for cellular proliferation
• Supports PI3K/Akt signaling research
• Supports MAPK/ERK pathway research
• Reduced binding to IGF-binding proteins
• Demonstrates strong activity in experimental models
• Convenient 1 mg presentation

Its defining feature is the reduced IGF-binding-protein interaction, which distinguishes DES(1-3) from native IGF-1 and makes it an interesting compound for advanced research into IGF-mediated muscle and cellular growth.

Side Effects

Because DES(1-3) IGF-1 has not been adequately evaluated in human clinical trials, its human side-effect profile is not well established. Effects associated with increased IGF-1 activity may include changes in blood glucose, headache, dizziness, fatigue, nausea, and fluid retention.

Where to buy 

Whenever bodybuilders want to buy steroids online, it’s always expected that the steroids shop they buy from – Strength Labz, for example – has the products they desire. And luckily, Strength Labz has Ultima-DES (1-3), 1 mg in stock.